Lee Scott Golden

Companies

• Cadrenal Therapeutics, Inc.Board member Dec 3, 2025 to now¹
• PTC TherapeuticsChief Medical Officer Jun 13, 2023 to now²
• MetaVia Inc.Chief Medical Officer Oct 6, 2016 to Jan 30, 2018³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PTC Therapeutics PTCT79,115 shares⁴$4.9M at $61.38Apr 2, 2026
• CTCadrenal Therapeutics, Inc. CVKD1,667 shares⁵$1.8K at $1.09Dec 3, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 2, 2026Sold 829 shares at $67.99 of PTC Therapeutics⁴
• Mar 5, 2026Sold 10,000 shares at $63.38 of PTC Therapeutics⁶
• Feb 18, 2026Sold 2,484 shares at $69.36 of PTC Therapeutics⁷
• Jan 8, 2026Sold 866 shares at $76.45 of PTC Therapeutics⁸
• Jan 7, 2026Sold 642 shares at $77.48 of PTC Therapeutics⁹
• Jan 6, 2026Sold 1,340 shares at $76.95 of PTC Therapeutics⁹
• Jan 2, 2026Granted 18,750 shares of PTC Therapeutics¹⁰
• Apr 2, 2025Sold 897 shares at $46.95 of PTC Therapeutics¹¹
• Feb 20, 2025Sold 962 shares at $50.12 of PTC Therapeutics¹²
• Feb 19, 2025Sold 795 shares at $50.10 of PTC Therapeutics¹²
• Jan 8, 2025Sold 1,198 shares at $44.50 of PTC Therapeutics¹³
• Jan 7, 2025Sold 810 shares at $45.34 of PTC Therapeutics¹³
• Jan 3, 2025Granted 20,000 shares of PTC Therapeutics¹⁴
• May 7, 2024Sold 175 shares at $32.82 of PTC Therapeutics¹⁵
• Apr 2, 2024Sold 526 shares at $28.37 of PTC Therapeutics¹⁶
• Feb 15, 2024Granted 2,600 shares of PTC Therapeutics¹⁷
• Feb 15, 2024Granted 20,000 shares of PTC Therapeutics¹⁷
• Jan 9, 2024Sold 1,225 shares at $29.01 of PTC Therapeutics¹⁸
• Jan 8, 2024Sold 775 shares at $28.64 of PTC Therapeutics¹⁸